to experience the full functionality of mail.com.
Enhanced by Google
Merck & Co Inc
August 05, 2016
US stocks rise to record highs after strong jobs report
U.S. stocks jumped to record highs Friday after a strong jobs report for the month of July gave investors more confidence ...
August 05, 2016
Bristol-Myers drug fails lung cancer study, shares plunge
A blockbuster cancer treatment failed in a key study as the drug's maker, Bristol-Myers Squibb, attempts to extend its usage ...
July 29, 2016
Merck posts strong 2Q numbers, while building for long term
Drugmaker Merck & Co., focused heavily on its long-term future as it builds sales of crucial new medicines Keytruda for ...
June 28, 2016
FDA approves first pill to treat all forms of hepatitis C
Federal health officials on Tuesday approved the first pill to treat all major forms of hepatitis C, the latest in a series ...
June 09, 2016
Merck to buy biotech drug developer Afferent Pharmaceuticals
Drugmaker Merck is buying Afferent Pharmaceuticals, a privately held biotechnology company developing a chronic cough ...
May 05, 2016
Merck beats 1Q profit views with tight cost controls
Merck posted an 18 percent jump in first-quarter income, beating Wall Street expectations, as reduced spending on marketing, ...
April 14, 2016
New tests for choosing right hep C drug could save money
New tests designed to help doctors pick the right hepatitis C medicine for patients could mean faster cures and lower costs.
April 13, 2016
Napster co-founder bankrolls project to speed cancer work
A project to speed development of cancer-fighting drugs that harness the immune system has academic and drug industry ...
March 25, 2016
Jury: Gilead owes Merck $200M in damages over drug patents
The federal jury in a patent trial has ordered drugmaker Gilead Sciences to pay Merck $200 million in damages for infringing ...
March 22, 2016
Jury finds for Merck in hepatitis drug fight with Gilead
A federal jury in California has ruled in favor of drugmaker Merck & Co. in a high-stakes lawsuit against rival Gilead ...
March 01, 2016
Study: $3B will be wasted on unused portion of cancer drugs
High prices for cancer medicines aren't the only reason they cost insurers and patients so much. Waste pads the bill, a study ...